Task force hopes to deliver affordable cancer drugs to developing countriesBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b4506 (Published 04 November 2009) Cite this as: BMJ 2009;339:b4506
- Zosia Kmietowicz
An international task force has been launched to expand the detection and treatment of cancer in less developed countries, where death rates from some cancers can be more than double those in richer nations.
A team of experts led by doctors from Harvard Medical School, Harvard School of Public Health, and the Dana-Farber Cancer Institute, hopes that the initiative will do for cancer patients what affordable drug pricing has achieved for people with HIV/AIDS, tuberculosis, polio, trachoma, and malaria in the developed world.
Felicia Knaul, head of the Harvard Global Equity Initiative, says that the task force will help to procure drugs for various cancers at affordable prices, expand the diagnosis and treatment of cancer, and improve survival.
Paul Farmer, from Harvard Medical School, who has been involved in building hospitals in developing countries, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial